LivaNova PLC (LIVN) Offers Update Following FDA Warning Letter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
LivaNova PLC Provides Update on FDA Warning Letter
January 5, 2016 2:15 PM ESTLONDON, Jan. 05, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ: LIVN) (LSE: LIVN) (the Company) received a Warning Letter dated December 29, 2015, from the United States Food and Drug Administration (FDA) alleging certain violations of FDA regulations applicable to medical device manufacturers at its Munich, Germany and Arvada, Colorado facilities.
The Company currently believes that less than 1 percent of 2016 consolidated sales could be impacted by this Warning Letter, and that FDAs concerns can be resolved without a material impact on the Companys financial results. Â Further... More



